176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-26.70%
Revenue decline while MRVL shows 21.15% growth. Joel Greenblatt would examine competitive position erosion.
-12.71%
Cost reduction while MRVL shows 27.99% growth. Joel Greenblatt would examine competitive advantage.
-52.07%
Gross profit decline while MRVL shows 15.71% growth. Joel Greenblatt would examine competitive position.
-34.61%
Both companies show margin pressure. Martin Whitman would check industry conditions.
9.02%
Similar R&D growth to MRVL's 9.77%. Walter Schloss would investigate industry innovation requirements.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.88%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
3.52%
Operating expenses growth while MRVL reduces costs. John Neff would investigate differences.
-9.58%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
9.66%
D&A growth above 1.5x MRVL's 3.50%. Michael Burry would check for excessive investment.
-95.26%
EBITDA decline while MRVL shows 557.44% growth. Joel Greenblatt would examine position.
-78.77%
EBITDA margin decline while MRVL shows 15.96% growth. Joel Greenblatt would examine position.
-94.74%
Operating income decline while MRVL shows 70.62% growth. Joel Greenblatt would examine position.
-92.82%
Operating margin decline while MRVL shows 75.75% growth. Joel Greenblatt would examine position.
-22.59%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-93.69%
Pre-tax income decline while MRVL shows 74.95% growth. Joel Greenblatt would examine position.
-91.39%
Pre-tax margin decline while MRVL shows 79.32% growth. Joel Greenblatt would examine position.
-93.69%
Tax expense reduction while MRVL shows 35.69% growth. Joel Greenblatt would examine advantage.
-93.69%
Net income decline while MRVL shows 69.85% growth. Joel Greenblatt would examine position.
-91.39%
Net margin decline while MRVL shows 75.11% growth. Joel Greenblatt would examine position.
-93.48%
EPS decline while MRVL shows 70.08% growth. Joel Greenblatt would examine position.
-92.31%
Diluted EPS decline while MRVL shows 70.08% growth. Joel Greenblatt would examine position.
1.07%
Share count reduction below 50% of MRVL's 0.67%. Michael Burry would check for concerns.
-7.56%
Diluted share reduction while MRVL shows 0.67% change. Joel Greenblatt would examine strategy.